Citadel Advisors
CUE icon

Citadel Advisors’s Cue Biopharma CUE Stock Holding History

Citadel Advisors’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,776
Closed -$60.1K – 14361
2024
Q2 		$103K Sell
2,776
-2,099
-43% -$104K ﹤0.01% 10867
2024
Q1 		$276K Buy
4,875
+3,181
+188% +$224K ﹤0.01% 9639
2023
Q4 		$134K Sell
1,694
-1,613
-49% -$115K ﹤0.01% 10565
2023
Q3 		$228K Buy
3,307
+1
+0% +$98 ﹤0.01% 9663
2023
Q2 		$362K Sell
3,306
-216
-6% -$25.4K ﹤0.01% 8641
2023
Q1 		$377K Buy
3,522
+2,988
+560% +$285K ﹤0.01% 8888
2022
Q4 		$45.7K Buy
+534
New +$48.8K ﹤0.01% 12248
2022
Q3 		– Sell
-6,801
Closed -$585K – 12758
2022
Q2 		$508K Buy
6,801
+6,389
+1,551% +$747K ﹤0.01% 8602
2022
Q1 		$60K Sell
412
-300
-42% -$63.6K ﹤0.01% 12676
2021
Q4 		$242K Buy
+712
New +$275K ﹤0.01% 11432
2021
Q3 		– Sell
-725
Closed -$253K – 13890
2021
Q2 		$253K Buy
+725
New +$281K ﹤0.01% 11667
2021
Q1 		– Sell
-928
Closed -$382K – 13225
2020
Q4 		$348K Sell
928
-6,320
-87% -$2.53M ﹤0.01% 8804
2020
Q3 		$3.27M Sell
7,248
-1,848
-20% -$1.06M ﹤0.01% 3841
2020
Q2 		$6.69M Buy
9,096
+8,462
+1,335% +$6.13M ﹤0.01% 2692
2020
Q1 		$270K Buy
+634
New +$307K ﹤0.01% 7511

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return

Citadel Advisors's CUE Position: Q3 2024 in Review

Citadel Advisors sold out of Cue Biopharma (CUE) in Q3 2024, closing a stake of 2,776 shares — an estimated $60.1K sold.

Citadel Advisors first reported a position in CUE in Q1 2020 and held it in 15 quarters. The position peaked at $6.69M in Q2 2020. 50 funds tracked by Wall St. Rank hold CUE as of Q3 2024.

  • Citadel Advisors reported no remaining Cue Biopharma position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 2,776 Cue Biopharma shares in Q3 2024, an estimated $60.1K.
  • Citadel Advisors first reported a position in Cue Biopharma in Q1 2020 and held it in 15 quarters.
  • Citadel Advisors's Cue Biopharma position peaked at $6.69M in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.